Press releases
- Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar Fibromatosis
- Endo Launches First Generic Version of Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) Capsules
- ENDO REPORTS FOURTH-QUARTER 2022 FINANCIAL RESULTS
- Endo Launches "Man With a Plan" Campaign to Support Men With Symptoms of Peyronie's Disease
Key statistics
As of last trade Endo International PLC (0Y5F:LSE) traded at 0.075, 7.14% above its 52-week low of 0.07, set on Dec 30, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 0.075 |
Average volume | 15.60k |
---|---|
Shares outstanding | 235.22m |
Free float | 233.36m |
P/E (TTM) | -- |
Market cap | 17.55m USD |
EPS (TTM) | -12.38 USD |
Data delayed at least 20 minutes, as of Mar 28 2023 17:49 BST.
More ▼